Neurobehavioral & Cognitive Disorders
Mental status examination
Jun. 28, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
07.03.2024
The use of eponyms in medical terminology has been a long-standing tradition, usually serving to honor the individuals who first described a disease or discovered its characteristics. However, as the understanding of diseases has advanced, the drawbacks of eponyms became apparent. Learning eponyms is challenging for students and patients, yet using eponyms is often the most practical option.
The case against eponyms
The benefits of descriptive disease names
Conclusion
There are good reasons for freeing the medical vocabulary from eponyms, yet there is room for exceptions. Certain eponyms are so deeply embedded in medical discourse and are so well known to the public that they are best left alone. Similarly, some eponyms are associated with disorders that are so complex in their clinical and biological manifestations that they cannot be described with reasonable brevity. A word of caution is also in order. Substituting acronyms for what they stand for and referring to diseases by obscure gene names are often as problematic as using eponyms.
References
Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377(2):162-72. PMID 28700839
Goetz CG. The history of Parkinson's disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med 2011;1(1):a008862. PMID 22229124
Garlapati P, Qurie A. Granulomatosis with polyangiitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022. PMID 32491759
Jennette JC, Falk RJ. Nosology of primary vasculitis. Curr Opin Rheumatol 2007;19(1):10-6. PMID 17143090
Teive HA, Lima PM, Germiniani FM, Munhoz RP. What's in a name? Problems, facts and controversies regarding neurological eponyms. Arq Neuropsiquiatr 2016;74(5):423-5. PMID 27191240
Woywodt A, Matteson E. Should eponyms be abandoned? Yes. BMJ 2007;335(7617):424. PMID 17762033
MedLink acknowledges the use of ChatGPT-4, an Artificial Intelligence chatbot, in drafting this blog entry.
Are you interested in being a guest blogger for MedLink Neurology? Contact us at editorial@medlink.com.
August 1, 2024
Thanks for inviting comments on the blog entry on eponyms for neurological diseases.
The author has many interesting points of view, but I must say, respectfully, that this topic is something I would not necessarily support if put to a vote. After over 50 years of neurology teaching and thousands of learners, I still think there is broad support for using eponyms for neurological disorders and signs, like the Babinski sign, for example.
We learn a lot from neurological teachers when they transfer precise knowledge to learners in packets of highly condensed knowledge, usually around the time of a diagnosis. This transfer may come in a formal lecture, book, or essay, but the knowledge is best delivered immediately, when it makes the most impact on the learner, and in context, which is best during a case evaluation. This occurs when the learner has that magical moment of clarity, and usually, they don’t forget it.
Think about it. Parkinson’s disease, Lou Gehrig’s disease, Guillain-Barré syndrome, Huntington’s disease, Miller-Fisher’s late-life migraine accompaniments, and Charcot Marie Tooth disease come to mind, let alone Alzheimer’s disease. For neurologists who have learned this way, these eponyms evoke this condensed knowledge. They can also act as aide-mémoires during the learning process.
I believe the use of eponyms, be it for diseases, anatomy, function, symptoms or signs, syndromes, or reflexes in neurology, remains defensible in this day and age. However, I may be showing my clinical and historical biases, and I do agree that if an eponym evokes a specific ethical problem, then it seems best to discuss it before discarding it.
Recently, I conducted a significant review of Brown-Sequard, his life and career, along with his famous syndrome, for a fall talk for our History of Medicine Society. It seems to me that this is one syndrome that most physicians appear to know. What a shame to just call it a “unilateral lesion of the spinal cord.”
I am sorry for being “old school,” as they say. I learned to cherish these eponyms and still use them in discussions with colleagues and learners, as well as people with neurological disorders and diseases. I do like change and new ideas, but I am just suggesting we walk carefully on this subject and get broad input and consensus before going down this route in neurology.
Please take my comments as constructive feedback. I will continue to check updates in MedLink and other neurology resources on this subject. This topic is highly debatable and can be and has been controversial.
I have not added any references to this response, but the Medlink Blog entry does help direct the reader to relatively new literature on the subject, albeit at the end of the blog entry it states that MedLink acknowledges the use of GPT-4 in drafting this blog entry. Perhaps, I would also add AI for Artificial Intelligence instead of GPT-4, and it would also be a new name for one of the authors, using the acronym AI?
Finally, for disclosure purposes, I am the author of Late-life migraine accompaniments in MedLink Neurology. It is a unique, clinically important area of migraine diagnosis and works best when linked to Dr. Miller-Fisher, a prominent Canadian/American neurologist.
R. Allan Purdy MD, FRCPC, FACP, FAHS
Professor Medicine (Neurology)
Dalhousie University
Halifax, Nova Scotia, Canada
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125